Cargando…
The Sphingosine Kinase 2 Inhibitor Opaganib Protects Against Acute Kidney Injury in Mice
INTRODUCTION: Acute kidney injury (AKI) is a common multifactorial adverse effect of surgery, circulatory obstruction, sepsis or drug/toxin exposure that often results in morbidity and mortality. Sphingolipid metabolism is a critical regulator of cell survival and pathologic inflammation processes i...
Autores principales: | Maines, Lynn W, Green, Cecelia L, Keller, Staci N, Fitzpatrick, Leo R, Smith, Charles D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677921/ https://www.ncbi.nlm.nih.gov/pubmed/36420520 http://dx.doi.org/10.2147/IJNRD.S386396 |
Ejemplares similares
-
Opaganib Protects against Radiation Toxicity: Implications for Homeland Security and Antitumor Radiotherapy
por: Maines, Lynn W., et al.
Publicado: (2022) -
Recent Progress in the Development of Opaganib for the Treatment of Covid-19
por: Smith, Charles D, et al.
Publicado: (2022) -
Organometallic small molecule kinase inhibitors – direct incorporation of Re and (99m)Tc into Opaganib®
por: Lengacher, Raphael, et al.
Publicado: (2021) -
Characterization of Isoenzyme-Selective Inhibitors of Human Sphingosine Kinases
por: Gao, Peng, et al.
Publicado: (2012) -
Opaganib in Coronavirus Disease 2019 Pneumonia: Results of a Randomized, Placebo-Controlled Phase 2a Trial
por: Winthrop, Kevin L, et al.
Publicado: (2022)